Clinical Trial

A Study to Evaluate the Efficacy and Safety of UI022/UI023

Name: A Study to Evaluate the Efficacy and Safety of UI022/UI023 — clinical trial record (NCT07600385)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

Efficacy and Safety of Combined Cilostazol and Rosuvastatin Therapy Versus Rosuvastatin Alone in Patients with Chronic Lower Extremity Peripheral Artery Disease: A Multicenter, Double-Blind, Randomized Controlled Trial

Trial Details

NCT Number	NCT07600385
Lead Sponsor	Korea United Pharm. Inc.
Conditions	Peripheral Arterial Disease
Enrollment	260 participants
Start Date	2019-03-12
Primary Completion	2022-05-03 (estimated)
Study Completion	2022-05-03 (estimated)
Updated on ClinicalTrials.gov	2026-05-20